Back to Search
CHERYL KHANNA, M.D.
M.D.
Ophthalmology Physician
NPI: 1982680401IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
36833(MN)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
MEDICAL COLLEGE OF WISCONSIN
Class of 1992
Research & Publications (20)
Murine osteosarcoma primary tumour growth and metastatic progression is maintained after marked suppression of serum insulin-like growth factor I.
PMID 19132750·Int J Cancer·2009
4-observational
Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin.
PMID 19597468·Oncogene·2009
8-other
Revisiting the seed and soil in cancer metastasis.
PMID 19401145·Int J Biochem Cell Biol·2009
6-review
Inhibition of AP-1 transcriptional activity blocks the migration, invasion, and experimental metastasis of murine osteosarcoma.
PMID 19074613·Am J Pathol·2009
7-preclinical
Catching cancer by the tail: new perspectives on the use of kinase inhibitors.
PMID 19470723·Clin Cancer Res·2009
7-preclinical
Inhibition of tumor cell motility by the interferon-inducible GTPase MxA.
PMID 19297326·J Biol Chem·2009
7-preclinical
Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature.
PMID 19330034·PLoS One·2009
3-trial
The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC.
PMID 19060919·Oncogene·2009
7-preclinical
Correlation between clinical outcome and growth factor pathway expression in osteogenic sarcoma.
PMID 19670450·Cancer·2009
8-other
Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton.
PMID 18676848·Cancer Res·2008
7-preclinical
Alterations in Gemin5 expression contribute to alternative mRNA splicing patterns and tumor cell motility.
PMID 18245461·Cancer Res·2008
8-other
Addiction to elevated insulin-like growth factor I receptor and initial modulation of the AKT pathway define the responsiveness of rhabdomyosarcoma to the targeting antibody.
PMID 18829562·Cancer Res·2008
7-preclinical
Novel targets with potential therapeutic applications in osteosarcoma.
PMID 18778562·Curr Oncol Rep·2008
6-review
Translation of new cancer treatments from pet dogs to humans.
PMID 18202698·Nat Rev Cancer·2008
6-review
Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma.
PMID 17823799·Cancer Chemother Pharmacol·2008
4-observational
Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases.
PMID 18071913·Clin Exp Metastasis·2008
7-preclinical
Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma.
PMID 17951400·Mol Cancer Res·2007
7-preclinical
Immune synapse formation requires ZAP-70 recruitment by ezrin and CD43 removal by moesin.
PMID 18025306·J Cell Biol·2007
7-preclinical
The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation.
PMID 18037895·Nat Med·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1982680401
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile